Metformin monotherapy for type 2 diabetes mellitus: Cochrane systematic review [sounds like]
13 results
1 - 13
Metformin monotherapy for type 2 diabetes mellitus: Cochrane systematic review
Metformin monotherapy for type 2 diabetes mellitus - Sulphonylurea monotherapy for patients with type 2 diabetes mellitus: Cochrane systematic review
- Alpha-glucosidase inhibitors for type 2 diabetes mellitus: Cochrane systematic review
- Sulphonylurea for type 2 diabetes
- Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
- Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
- Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus